Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for cancer--managing expectations

A A Melcher1, I Garcia-Ribas, R G Vile

  • 1Imperial Cancer Research Fund, Molecular Oncology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London.

BMJ (Clinical Research Ed.)
|January 23, 1998
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OX40 and 4-1BB delineate distinct immune profiles in sarcoma.

Oncoimmunology·2022
Same author

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.

Clinical and experimental immunology·2019
Same author

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.

Gene therapy·2016
Same author

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.

Leukemia·2015
Same author

Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.

Clinical and experimental immunology·2014